China SXT Pharmaceuticals Debt-to-Equity Ratio Growth & History (SXTC)
China SXT Pharmaceuticals's debt-to-equity ratio was 0.04 for fiscal 2026.
View full China SXT Pharmaceuticals company overviewChina SXT Pharmaceuticals annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | 0.04 | −0.03 | −40.78% |
| 2025 | 2025-03-31 | 0.06 | 0.00 | +2.34% |
| 2024 | 2024-03-31 | 0.06 | 0.02 | +52.65% |
| 2023 | 2023-03-31 | 0.04 | −0.13 | −76.61% |
| 2022 | 2022-03-31 | 0.17 | 0.17 | +6311.82% |
| 2021 | 2021-03-31 | 0.00 | −0.01 | −68.20% |
| 2020 | 2020-03-31 | 0.01 | 0.00 | +36.66% |
| 2019 | 2019-03-31 | 0.01 | — | — |
China SXT Pharmaceuticals quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | 0.04 | −0.03 | −40.78% |
| Q2 2026 | 2025-09-30 | 0.06 | −0.01 | −14.00% |
| Q4 2025 | 2025-03-31 | 0.06 | 0.00 | +2.34% |
| Q2 2025 | 2024-09-30 | 0.07 | −0.06 | −46.38% |
| Q4 2024 | 2024-03-31 | 0.06 | 0.02 | +52.65% |
| Q2 2024 | 2023-09-30 | 0.13 | 0.03 | +36.21% |
| Q4 2023 | 2023-03-31 | 0.04 | −0.13 | −76.61% |
| Q2 2023 | 2022-09-30 | 0.09 | 0.09 | +5331.70% |
| Q4 2022 | 2022-03-31 | 0.17 | 0.17 | +6311.82% |
| Q2 2022 | 2021-09-30 | 0.00 | −0.00 | −47.05% |
| Q4 2021 | 2021-03-31 | 0.00 | −0.01 | −68.20% |
| Q2 2021 | 2020-09-30 | 0.00 | −0.07 | −95.64% |
| Q4 2020 | 2020-03-31 | 0.01 | 0.00 | +36.66% |
| Q2 2020 | 2019-09-30 | 0.08 | — | — |
| Q4 2019 | 2019-03-31 | 0.01 | — | — |
China SXT Pharmaceuticals debt-to-equity ratio trends
Over the last five fiscal years, China SXT Pharmaceuticals's debt-to-equity ratio increased from 0.00 to 0.04, a change of 0.04. The latest reported quarter, Q4 2026, shows 0.04.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review China SXT Pharmaceuticals source filings ↗